can semaglutide cause pancreas problems Ozempic and GLP-1 Drugs: Risk of Severe Side Effects Small risk of severe acute

GLP-1 receptor agonists are approved for weight management in non-diabetic adults who meet clinical criteria for overweight or obesity, under medical supervision.v No specific restrictions, but a balanced diet with adequate hydration helps reduce gastrointestinal side effects and enhances results

Moreover, it influences dietary choices by decreasing the inclination towards high-fat foods

IGF-1 LR3 is not approved as a medicinal product in most countries, including Germany and other EU member states

Semaglutide injection activates GLP-1 receptors in your brain and gut within hours, which means side effects can appear quickly after your first dose